Abstract. The role of the simian virus 5 (SV5) fusion (F) protein 20 residue COOH-terminal region, thought to represent the cytoplasmic tail, in fusion activity was examined by constructing a series of COOH-terminal truncation mutants. When the altered F proteins were expressed in eukaryotic cells, by using the vaccinia virus-T7 transient expression system, all the F proteins exhibited similar intracellular transport properties and all were expressed abundantly on the cell surface. Quantitative and qualitative cell fusion assays indicated that all of the F protein COOH-terminal truncation mutants mediated lipid mixing with similar kinetics and efficiency as that of wild-type F protein. However, the cytoplasmic content mixing activity decreased in parallel with the extent of the deletion in the F protein COOH-terminal truncation mutants. These data indicate that it is possible to separate the presumptive early step in the fusion reaction, hemifusion, and the final stage of fusion, content mixing, and that the presence of the F protein COOH-terminal region is important for the final steps of fusion.
M
EMBRANE fusion is an essential biochemical process critical for intracellular membrane trafficking, fertilization, and synaptic transmission. Enveloped virus-induced fusion has been one of the best characterized membrane fusion reactions. The entry of enveloped viruses into cells occur by fusion of the viral membrane with either the host cell plasma membrane or with the membrane of an endocytic vesicle. With many enveloped viruses, membrane fusion is induced by a fusogenic spike glycoprotein which is also responsible for attachment of viral particles to the target cell. With the paramyxoviruses, however, the functions of attachment and fusion are mediated by two different spike glycoproteins (Scheid et al., 1972;  for review see Stegmann et al., 1989; White, 1990) .
Simian virus 5 (SV5) ~ is a member of the family paramyxoviridae and contains two integral membrane spike glycoproteins, the hemagglutinin-neuraminidase protein (HN), and the fusion protein (F) (Paterson et al., 1984b (Paterson et al., , 1985 Scheid et al., 1972; Scheid and Choppin, 1974) . The HN protein provides the attachment function allowing the virus particle to bind to sialic acid containing receptors on the cell surface, whereas the F protein is directly involved in virus-induced membrane fusion. The F protein is a type I integral membrane protein and computer-assisted analysis indicates that it contains a 484-residue ectodomain, a 25-residue transmembrane domain, and a 20-residue cytoplasmic tail (Paterson et al., 1984b , Lamb, 1993 . It is synthesized as an inactive precursor (F0) which is cleaved by a cellular protease in the trans-Golgi apparatus (Klenk and Garten, 1994; Scheid and Choppin, 1974) to form the biologically active protein consisting of the disulfide linked chains F t and F 2.
It has become increasingly clear that there is a difference in the requirements for fusion among different paramyxoviruses (Bagai and Lamb, 1995b; . Whereas most of the paramyxoviruses require the coexpression of homotypic F and HN proteins in order to induce cell-cell fusion (Ebata et al., 1991; Hu et al., 1992; Morrison et al., 1991; Sergel et al., 1993; Tanabayashi et al., 1992; Wild et al., 1991) , a homotypic HN protein is not essential for SV5 F protein-mediated cell fusion (Bagai and Lamb, 1995b) . Further evidence for the sufficiency of SV5 F protein in cell fusion comes from the finding that F mutants containing single Gly to Ala changes in the fusion peptide cause a remarkable increase in the syncytia formation compared to the wild-type (wt) F protein Ward et al., 1995) . To understand the mechanism of F protein-induced membrane fusion, it is important to understand the role of different domains of the F protein in mediating fusion. While it is known that the fusion peptide and adjacent heptad repeat regions have important roles in fusion Sergel-Germano et al., 1994; Wang et al., 1992) , the role of the cytoplasmic tail of the F proteins is less clear. Studies with human immunodeficiency virus type 2 and simian immunodeficiency virus envelope glycoproteins (env) have shown that cytoplasmic tail truncation mutants significantly enhance syncytia formation and alter the conformation of the external domain of env (Mulligan et al., 1992; Ritter et al., 1993) . For the paramyxoviruses, examination of the role of the F protein cytoplasmic tail in fusion has led to disparate results: for Newcastle disease virus, F protein cytoplasmic tail deletions greatly reduced syncytia formation (Sergel and Morrison, 1995) , for human parainfluenza virus type 3, the F protein cytoplasmic tail mutants showed reduced cell surface expression due to a defect in oligomerization, and for human parainfluenza virus type 2, F protein cytoplasmic tail deletions did not affect fusion (Yao and Compans, 1995) . However, in all of these studies, the effect of mutations in the cytoplasmic tail on the final extent of fusion was examined and the early steps in fusion were not investigated.
Recent studies with a glycosyl phosphatidyl inositol (GPI)-linked form of influenza virus hemagglutinin (HA), where the HA lacks its normal transmembrane and cytoplasmic domains, have shown that GPI-anchored HA is competent in mediating fusion of the outer leaflets of the lipid bilayer (hemifusion) but there was no mixing of the aqueous contents (content mixing) (Kemble et al., 1994; Melikyan et al., 1995) . It has been suggested for influenza virus HA that separate domains of HA may control individual steps in fusion (Kemble et al., 1994; Melikyan et al., 1995) . The present study was undertaken to define the requirement of the cytoplasmic domain of the SV5 F protein in the membrane fusion process, using quantitative biophysical assays to measure the kinetics of membrane fusion and the extent of content mixing and employing qualitative fluorescence measurements to follow the movement of membrane and aqueous dyes. The results indicate that hemifusion but not complete fusion occurs in the absence of the cytoplasmic domain of the SV5 F protein. We interpret these data to indicate that hemifusion is an intermediate step common to virus-mediated membrane protein fusion.
Materials and Methods

Cells and Recombinant Plasmid Vectors
Monolayer cultures of the TC7 subclone of CV-1 cells and HeLa-T4 cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% NU Serum IV (Collaborative Research Laboratories, Inc., Bedford, MA) as described previously (Paterson et al., 1985) .
The SV5 F and HN cDNAs described previously Paterson et al., 1984a, b) were subcloned into pGEM2X, a derivative of pGEM2 containing an XhoI site (Bagai and Lamb, 1995b) . The plasmid pTF7.5 containing the hemagglutinin (HA) cDNA of influenza virus A/ Udorn/72 was described previously (Simpson and Lamb, 1992) . The plasmid pGINT7 13-gal (Nussbaum et al., 1994) containing the [3-galactosidase cDNA was kindly provided by Drs. Edward Berger and Bernard Moss (National Institutes of Health, Bethesda, MD). All the cDNAs were cloned in pGEM2X in an orientation such that mRNA-sense RNA transcripts could be synthesized by using bacteriophage T7 RNA polymerase.
Oligonucleotide-directed Mutagenesis and Generation ofF Protein COOH-Terminal Truncation Mutants
pGEM2X-F was used as the template for mutagenesis. Clones encoding the SV5 F protein COOH-terminal truncation mutants A5, A10, A15, and A19 were constructed by oligonucleotide-directed unique site elimination (U.S.E) mutagenesis (Deng and Nickoloff, 1992) by introducing premature translational stop codons into the coding sequence to obtain COOHterminal deletions of 5, 10, 15, and 19 residues, respectively. In addition to the COOH-terminal truncation mutants, a revertant BWT (back wt) was also constructed by replacing the translational stop codon in mutant A19 with the codon for leucine. U.S.E mutagenesis was performed using the U.S.E. TM mutagenesis kit following the instructions of the supplier (Pharmacia Biotech, Inc., Piscataway, N J).
Oligonucleotides were synthesized by the Northwestern University Biotechnology Facility on a DNA synthesizer (model 380B, Applied Biosystems, Inc. Foster City, CA). The nucleotide sequence of the F protein COOH-terminal truncation mutants was determined by dideoxynucleotide chain-terminating sequencing (Sanger et al., 1977) .
Expression ofF Protein COOH-Terminal Truncation
Mutants and Metabolic Labeling of Cells
The mutant F proteins were expressed by using the vaccinia virus-bacteriophage T7 RNA polymerase transient expression system (Fuerst et al., 1986) . Subcontinent monolayers of HeLa-T4 or CV-1 cells were infected with recombinant vaccinia virus vTF7-3 at a multiplicity of infection of l0 pfu/cell and incubated at 37°C for 45 min. The virus inoculum was removed and cells were transfected with wt and mutant plasmid DNA using cationic liposomes made in our laboratory as described previously (Rose et al., 1991) . Transfection was done according to the protocol for using TransfectACE TM (GIBCO BRL, Gaithersburg, MD) essentially as described (Rose et al., 1991) . Typically 2.5 ~g of plasmid DNA was used for a 35-mm tissue culture dish and the volume was adjusted to 0.5 ml with OPTI-MEM (GIBCO BRL). At 5 h posttransfection, cells were washed twice in phosphate-buffered saline and incubated in cysteine-and methionine-deficient DMEM (DMEM Cys-Met-) for 30 min. For pulsechase experiments, cells were labeled with Tran-ass-label (100 ~Ci per ml) (ICN Radiochemicals, Irvine, CA) in DMEM Cys-Met-for the pulse period indicated. The chase period was initiated by removal of the labeling medium, the cells were washed with prewarmed chase medium (DMEM supplemented with 2 mM unlabeled cysteine and methionine and 2% NU serum IV), and then additional chase medium was added. The cells were then incubated for varying periods after which they were lysed in ice-cold RIPA buffer containing protease inhibitors (Paterson and Lamb, 1987) and 25 mM iodoacetamide.
Chemical Cross-Linking
HeLa-T4 cells expressing the SV5 wt F and COOH-terminal truncation mutant proteins were labeled with Tran-aSS-label (100 IxCi per ml) in DMEM Cys-Met for 30 min at 5 h posttransfection and incubated in chase medium for 2 h. Chemical cross-linking analysis was performed as described previously (Russell et al., 1994) using the cross-linking reagent 3,3'-dithiobis(sulfosuccinirnidyl propionate) (DTSSP) (Pierce Chemical Co., Rockford, IL).
Immunoprecipitation, SDS-PAGE, and Quantification of Autoradiograms
F proteins were immunoprecipitated from cell lysates by using a rabbit antiserum raised against a mixture of three synthetic peptides specific for F2 residues 22 to 39, 31 to 46, and 77 to 94 . Immunoprecipitation was performed as described previously (Lamb et al., 1978) . Polypeptides were analyzed by SDS-PAGE. Cross-linked polypeptides were analyzed on 3.5% acrylamide gels (Gething et al., 1989; Russell et al., 1994) , nonreduced F polypeptides on 10% acrylamide gels and reduced F polypeptides on 15% acrylamide gels, and gels were processed for fluorography as described previously (Lamb and Choppin, 1976; Paterson and Lamb, 1993) . Autoradiograms were quantified by using a laser densitometer (LKB Ultrascan; Pharmacia-LKB, Inc., Piscataway, N J) equipped with LKB Gelscan SL software.
Endo-fl-N-acetylglucosaminidase Digestions
To test for the conversion of N-linked carbohydrate chains from high mannose to the complex form, immune complexes were digested with 1 mU of endoq3-N-acetylglucosaminidase (endo H) (Boehringer-Mannheim Biochemicals, Indianapolis, IN) as described previously (Ng et al., 1989) . Pep-tide N-glycosidase F and deoxymannojirimycin (DMJ, 0.5 mM) treatments were done as described previously (Melikyan et al., 1995; Paterson and Lamb, 1993) .
Quantification of Surface Expression: FA CS Analysis
For flow cytometry, HeLa-T4 cells were grown on culture dishes (6 cm) to 70% confluence. At 5 h posttransfection, cells were chilled on ice and treated for flow cytometric analysis as described previously using monoelonal antibody F1 a specific for the SV5 F glycoprotein (Randall et al., 1987) as the primary antibody and fluorescein isothiocyanate--conjugated goat anti-mouse IgG as the secondary antibody. Fluorescence intensity of 10,000 cells was measured by a FAC-SCAN flow cytometer (Becton Dickinson, Mountain View, CA).
Incorporation of Fluorescent Probes into Erythrocytes
Fresh human red blood cells (RBCs) were labeled either singly or colabeled with membrane and aqueous dyes. Labeling of RBCs with the lipid probe octadecyl rhodamine B (R18) was carried out as described previously (Bagai and Lamb, 1995b) . Entrapment of the aqueous dye NBDtaurine was done as described previously (Sarkar et al., 1989) . RBCs were colabeled with R18 and NBD-taurine by injecting 15 ~l of 1 mg/ml R18 in ethanol to the RBCs suspended in 10 mM NBD-taurine in PBS at 37°C as described (Sarkar et al., 1989) . After labeling, the RBC suspension was washed six times with 50 ml PBS to remove the unincorporated RI8 and NBD-taurine. The double-loaded erythrocytes could be stored for 2-3 d without significant leakage of dyes. RBCs were loaded with either the fluorescent aqueous dye ethidium bromide (EtBr) or HOECHST 33258 by mild hypotonic lysis as described previously (Ellens et al., 1989) . The hypotonic solution contained either i mM ethidium bromide or HOECHST 33258 in 10 mM Tris-HCl, 0.5 mM EGTA, pH 7.5. More than 90% of the cells trapped the dyes.
Binding and Fusion of Loaded RBCs with Cells Expressing Viral Envelope Proteins: Fluorescence Microscopy
CV-1 cells grown on coverslips and expressing wt or mutant F and wt HN proteins at 5 h posttransfection were washed twice and incubated overnight at 32°C in DMEM containing 10% NU serum IV. The cells were washed with PBS, incubated for 1 h at 37°C with 50 mU per ml of neuraminidase (Vibrio cholerae) (Boehringer Mannheim, Indianapolis, IN) in DMEM and washed twice with PBS. 3 ml of (co)labeled RBCs (0.1% hematocrit) in PBS were added to the monolayer and incubated at 4°C for 30 rain with occasional gentle agitation, Unbound RBCs were removed by six washes with PBS. Fusion was triggered by transferring the coverslips to 37°C for varying time periods and coverslips were then placed on microscope slides and cells photographed with a Nikon Microphot FXA microscope system (Nikon Corp., Tokyo, Japan). NBD fluorescence was visualized under a "fluorescein" filter set, R18 and EtBr fluorescence was observed with a "Texas red" filter set, and HOECHST 33258 fluorescence under a"DAPI" filter set.
Spectrofluorometric Measurements
For measurement of kinetics of lipid mixing, R18 labeled erythrocytes bound to cells as described above were removed from the dish using either trypsin-EDTA solution or 50 mM EDTA in PBS at 4°C. The R18-1abeled RBC-acceptor cell complexes were washed with cold PBS and placed on ice until further use. Fluorescence changes as a result of fusion of R18-labeled erythrocytes with acceptor cells were measured continuously using a spectrofluorimeter (Alpha Scan, Photon Research Inc., South Brunswick, N J) with 1 s time resolution at 560/590 nm excitation and emission, respectively. A 570-nm cut off filter was placed in the emission optical pathway to reduce scattering. 50 gl of the R18-1abeled RBC and acceptor cell suspension was placed into a cuvette containing 3 ml PBS prewarmed to 37°C. To normalize the data, percent fluorescence dequenching (% FDQ) at any time point was calculated according to the following equation: % FDQ = 100. (F-FdFt-F~ 0 where Fcl and F are the fluorescence intensities at time 0 and at a given time point. Ft is the fluorescence intensity in the presence of 0.1% Triton X-100 and defined as fluorescence at "infinite" dilution of the probe (Bagai et al., 1993) .
Content Mixing Assay
The content mixing assay based on the cytoplasmic activation of the reporter gene 13-galactosidase was performed essentially as described (Nussbaum et al., 1994) with slight modifications. The cells expressing viral envelope proteins at 5 h posttransfection were trypsinized, suspended in DMEM containing 2.5% NU serum IV to a density of 2 X 10S/ml, and incubated overnight at 32°C in a near horizontal position. The cells were washed twice in OPTI-MEM (containing 2.5 mM CaCI2), suspended to a density of 2 x 107/ml, and treated with neuraminidase (50 mU/ml) for I h at 37°C. The ceils were then washed and suspended in OPTI-MEM at 106 cells/ml. A second population of CV-1 ceils was infected with wt vaccinia virus (strain WR) for 45 rain at 37°C and transfected with plasmid pGINT7 [3-gal. At 5 h posttransfection, cells were washed and incubated overnight as described above. The cells were washed with OPTI-MEM. The two cell populations were mixed in triplicate by adding 100 ~1 of each cell population in a 96-well tissue culture plate. The plates were incubated at 37°C for 4 h. Cell fusion was measured at the indicated times by using a colorimetric lysate assay for 13-galaetosidase as described previously (Nussbaum et al., 1994) . The quantity of [3-galactosidase was calculated by comparing the rates of hydrolysis for each sample with that obtained for a standard preparation of E. coil 13-galactosidase (Boehringer Mannheim) and was expressed as ng/well. The in situ assay involving X-gal staining of cells was done as described previously (Nussbaum et al., 1994) .
Results
Construction and Expression ofF Protein COOH-Terminal Truncation Mutants
The transmembrane domain of a type I integral membrane protein is defined as the carboxyl-terminal hydrophobic domain, usually bounded by two charged residues, which acts during synthesis to stop the transfer of the nascent polypeptide chain across the bilayer and brings its stable integration in the membrane. In the case of the paramyxovirus SV5 F protein, computer-assisted analysis of the hydrophobieity of the F protein suggests that the transmembrane domain begins at F residue 485 after a series of serine and threonine residues and ends before a lysine residue at F residue 510, yielding a 25-residue transmembrane domain. Thus, the cytoplasmic tail is presumed to consist of 20 COOH-terminal residues. To examine the role of the paramyxovirus SV5 F protein cytoplasmic tail in membrane fusion, translational stop codons were introduced into the cytoplasmic tail. Four deletion mutants were constructed and they were designated A5, A10, A15, and A19 and their cytoplasmic tails contained deletions of 5, 10, 15, and 19 amino acids, respectively (Fig. 1) . The A19 mutant has the entire cytoplasmic tail deleted except for one positively charged lysine that immediately follows the transmembrane domain and marks the presumptive junction of the transmembrane and the cytoplasmic domain.
The F protein COOH-terminal truncation mutants were expressed in HeLa-T4 cells by using the recombinant vaccinia virus-T7 RNA polymerase system. To analyze the expression and cleavage of F 0 to F 1 and F2, the cells were labeled with Tran-35S-label for 15 rain and were either lysed immediately or incubated in chase medium for 3 h. Proteins were immunoprecipitated and polypeptides were analyzed by SDS-PAGE. As shown in Fig. 2 A, all the proteins were expressed and a significant fraction of the F proteins was cleaved to Ft and F 2 after a 3-h chase period. In the case of mutant A19, only a weak band corresponding to F1 polypeptide could be identified but a diffuse band of higher mobility than that expected for F I was also ob- served. This diffuse band is thought to be a heterogeneously glycosylated form of F~ as on treatment of cells with deoxymannojirimycin, an inhibitor of a-mannosidase I, a discrete F1 band was observed (data not shown).
Oligomerization of SV5 F Protein COOH-Terminal Truncation Mutants
We have shown that the F protein forms a homo-oligomer shortly after its synthesis in the E R (Russell et al., 1994) and the data is consistent with the formation of a homotrimer, As some cytoplasmic tail mutants have the propensity to cause profound alterations to native protein folding and oligomerization, and in turn affect intracellular transport of the glycoproteins (Parks and Lamb, 1990; Rose and Bergmann, 1983; Sergel and Morrison, 1995) , it was important to examine the effect of the F protein cytoplasmic tail mutations on oligomerization and transport properties of the protein. To assess the competence of altered F proteins to form oligomers (trimers), chemical cross-linking studies were done. HeLa-T4 cells expressing the truncation mutants were labeled with Tran-35S-label at 5 h posttransfection for 30 rain at 37°C and cultures were incubated in chase medium for 2 h to allow for intracellular transport to the plasma membrane. Cross-linking reactions were performed using the homobifunctional reagent DTSSP on either intact cells, to react with the cell surface F molecules, or on detergent solubilized (NP-40) cell extracts to render all F molecules available for cross-linking. As shown in Fig. 2 B all the F protein C O O H -t e r m i n a l truncation mutants could be cross-linked to homotrimers (species 3) both in the presence and absence of the detergent, indicating intracellular oligomer formation. The cross-linking pattern observed (species 1, 2, and 3) was found to be consistent with that observed previously when cross-linking studies were performed using SV5 virusinfected cells (Russell et al., 1994) . Thus, all the F protein mutants could form oligomers similar to that of the wt F Figure 2 . Expression and oligomeric form of the F protein COOH-terminal truncation mutants. (A) To express the altered F proteins, HeLa-T4 cells were infected with vaccinia virus vTF7-3 at 10 pfu per cell for 45 min at 37°C and then transfected with plasmids encoding wt and mutant F proteins as described in Materials and Methods. Transfected cells were metabolically labeled with Tran-35S-label (100 txCi/ml) at 5 h posttransfection for 15 min and incubated in chase medium for 0 or 3 h. Polypeptides were immunoprecipitated with F2-specific antiserum and analyzed by SDS-PAGE on 15% gels under reducing conditions. Mock represents polypeptides immunoprecipitated from vTF7-3 infected but untransfected cells. Radioactivity was detected by fluorography. (B) HeLa-T4 cells expressing the F protein COOH-terminal truncation mutants were labeled with Tran-35S-label (100 IxCi/ml) at 5 h posttransfection for 30 rain and incubated in chase medium for 2 h at 37°C. Cross-linking reactions were performed on cell suspensions in the absence ( -) or presence (+) of 0.5% NP-40 as described in Materials and Methods. F protein species were immunoprecipitated and polypeptides analyzed on a 3.5% gel under nonreducing conditions. The three predominant species are indicated by arrows.
protein
Analysis of the Rate of lntracellular Transport of the F Protein COOH-Terminal Truncation Mutants
To determine the effect of the C O O H -t e r m i n a l region deletion mutations on transport of F proteins to the medialGolgi apparatus, the rate of acquisition of carbohydrate chains resistant to endo H digestion was analyzed. Acquisition of endo H resistance is indicative of the conversion of carbohydrate chains from the simple to the complex form in the medial-Golgi compartment. We have shown previously that the two carbohydrate chains on the F2 subunit remain in the high mannose form and do not acquire resistance to endo H digestion (Bagai and Lamb, 1995a; . However, most of the F1 subunit carbohydrate chains acquire endo H resistance.
When the rate of transport to the medial-Golgi apparatus of the wt F protein expressed using the vaccinia virus-T7 system was determined, it was found to acquire endo H resistance with a tt/2 ~7 0 -7 5 min. By 180 min, > 9 0 % of the F molecules were transported to the medial-Golgi apparatus (Fig. 3 A) . Mutants A5, A10, A15, and A19 all showed rates of loss of carbohydrate chains sensitive to endo H digestion that were very similar to that for wt F protein (Fig.  3 A) : quantification was done relative to the loss of the sensitive form, as the resistant form of A19 was heterogeneous in migration and difficult to quantify. Hence, the deletion in C O O H -t e r m i n a l domain of the F protein did not have a major effect on the rate of transport of the proteins to the medial-Golgi apparatus.
Cleavage of F 0 to Ft and F2 occurs during its transit from 
Bagai and Lamb Hemificsion and Complete Fusion
the trans-Golgi apparatus (Klenk and Garten, 1994; Morrison et al., 1985) . To determine the rate of transport of the mutant F proteins to the cleavage compartment, HeLa-T4 cells expressing the mutant F proteins at 5 h posttransfection were metabolically labeled with Tran35S-label for 15 min, the cultures incubated in the chase medium for various time periods and the F polypeptides immunoprecipitated and the F0, F1 and F2 polypeptides were analyzed by SDS-PAGE. The amount of F0, as a percentage of total F polypeptide species was determined by densitometric scanning of autoradiographs (Fig. 3 B) . The rate of cleavage for all the mutants was found to be similar to that of wt F protein; however, the final extent of cleavage was somewhat lower for mutant A15 as compared to that of wt F protein. For both wt F protein and the mutants, cleavage did not reach completion even after 180 min of chase period and only 50% of the molecules were found to be cleaved in 3 h. This finding is consistent with our earlier studies using the vaccinia virus transient expression system (Bagai and Lamb, 1995a) , whereas in SV5 virus-infected cells cleavage of F goes to completion in 3 h . It is thought that the high level expression of F protein using the vac-T7 expression system saturates the amount of available cleavage enzyme, furin, present in the TGN (Klenk and Garten, 1994) . Nonetheless, the rate and extent of cleavage was very similar for all the mutants and, as will be shown below, sufficient active F proteins are expressed to readily measure fusion activity.
Surface Expression of the F Protein COOH-Terminal Truncation Mutants
The cell surface expression of the altered F proteins was quantified by flow cytometry. Cells were stained with F-specific mAb, Fla. As shown in Table I , all the mutants showed both a comparable percentage of positive cells as compared to wt F protein and exhibited a similar mean fluorescent intensity (MFI) except for mutant A15 which had a somewhat reduced MFI, a finding which correlates with its somewhat reduced rate of cleavage (Fig. 3 B) .
Induction of Cell Fusion by the F Protein COOH-Terminal Truncation Mutants
Cell fusion involves both the mixing of the outer leaflet membrane lipids and the mixing of inner leaflet membrane lipids with concomitant mixing of aqueous contents of donor and recipient cells (Kemble et al., 1994) . We therefore determined the ability of CV-1 cells expressing the wt F or COOH-terminal truncation mutants to fuse with target red blood cells (RBCs) prelabeled with fluorescent lipid and fluorescent soluble content probes either singly or in combination.
Lipid mixing activity of F protein COOH-terminal truncation mutants: Kinetics.
To obtain information about the rates and extents of wt F or mutant F protein induced fusion, we measured the kinetics of fluorescence dequenching of the lipophilic probe R18. The lipid probe R18 was incorporated into RBCs which were then mixed with the acceptor cells expressing the wt F or the COOH-terminal truncation mutants. As this assay is done in suspension, the F protein expressed alone yields no fluorescence dequenching on mixing with R18 labeled erythrocytes (Bagai and Lamb, 1995b) because the binding of one cell to another requires either the paramyxovirus sialic acid binding glycoprotein HN or the influenza virus sialic acid-binding protein HA. As shown in Fig. 4 , wt F protein and the COOH-terminal truncation mutant F proteins coexpressed with HN mediated rapid and efficient lipid mixing. The kinetics of fluorescence dequenching was comparable for wt F protein and all the truncation mutants. The F proteinmediated fusion was inhibited by preincubation of R18 labeled RBC-acceptor cell suspensions with a monoclonal antibody specific to SV5 F protein, strongly suggesting that the fluorescence dequenching observed on coexpression of F and HN is due to the specific fusion activity of the F protein and is not an artifact as a result of nonspe- cific dye transfer. Lipid mixing activity was also determined when the F proteins were coexpressed with HA. Significant fluorescence dequenching was observed and again the kinetics of fusion was similar for all the F protein COOH-terminal truncation mutants and the wt F protein when the F proteins were coexpressed with influenza HA. However, the rates as well as the extents of lipid mixing were found to be lower with the heterotypic-binding protein, confirming our earlier data (Bagai and Lamb, 1995b) . Hence, the lipid mixing activity of the F protein C O O Hterminal truncation mutants appears in all aspects to be the same as wt F protein.
Content mixing activity of the F protein COOH-terminal truncation mutants.
We employed the reporter gene ([3-galactosidase) activation assay (see Materials and Methods) to measure the content mixing potential of the F protein Figure 5 . Reporter gene activation assay (content mixing) for the F protein COOHterminal truncation mutants. One culture of CV-1 cells was infected with recombinant vaccinia virus vacTF7-3, which encodes T7 RNA polymerase, and cotransfected with plasmid DNA encoding the cDNAs for the SV5 HN and wt F or the F protein COOH-terrninal truncation mutant proteins. Cells were then treated with bacterial neuraminidase as described in Materials and Methods. A second culture of CV-1 cells was infected with wt vaccinia virus (strain WR) and transfected with plasmid pGINT713-gal which encodes [3-galactosidase. The cell populations were washed and suspended in OPTI-MEM containing CaC12 (2.5 mM) at 106 per ml. Mixtures of the two populations of cells (0.1 ml each) were plated in triplicate in 96-well plates and incubated at 37°C. (Top) After incubation at 37°C for 4 h, samples were analyzed by using in situ X-gal staining (Materials and Methods). Cells were photographed using a Kodak Digital 420 camera at 10 x magnification on a Nikon inverted phase contrast microscope. (Bottom) Samples were analyzed by the colorimetric lysate assay as described in Materials and Methods. Each point represents an average of three experiments _ SD. BWT represents mutant A19 that was reverted back to wt as described in Materials and Methods.
COOH-terminal truncation mutants. The [3-galactosidase activity was analyzed by in situ X-Gal staining assay (Fig.   5, top) and by a quantitative colorimetric assay for 13-galactosidase activity (Fig. 5, bottom) . In contrast to the data obtained for lipid mixing, the content mixing activity of the F protein COOH-terminal truncation mutants was found to decrease in parallel with the extent of the deletion of the F protein cytoplasmic tail (Fig. 5) . The reduced content mixing activity observed with mutant A15 could be due to its lower surface expression level (Table I) but we do not believe this is the case as the lower expression level of A15 did not affect the rate or extent of lipid mixing activity. The most striking effect of the COOH-terminal deletions on content mixing was observed with mutant A19 where the level of 13-galactosidase activity detected was similar to background levels observed when mock-infected cells were used in the assay.
To confirm that the complete loss in the content mixing activity in mutant A19 was a result of deletion of the F protein COOH-terminal and not due to another mutation that might have been inadvertently introduced in the F gene during mutagenesis, the back mutant (BWT) was made in which the translational stop codon was converted to leucine. As shown in Fig. 5 , the content mixing activity was found to be completely restored in BWT confirming that the loss of the content mixing activity in mutant A19 is due to the lack of the F protein COOH-terminal domain. To determine whether the presence of the heterogenous carbohydrate chains on the FI subunit of mutant A19 contributed to loss of content mixing activity, cells were treated with DMJ during expression of wt F protein and mutant A19 and during the content mixing assay. It was found that the content mixing activity of wt F protein was unaffected by DMJ treatment, and that treatment with DMJ did not restore detectable content mixing activity to mutant A19. Thus, taken together these findings indicate that, in contrast to the lipid mixing results, the removal of the COOH-terminal domain completely abolishes the content mixing activity.
Microscopy: Lipid dye but not aqueous dye spreads between RBCs and mutant A19 expressing cells under fusogenic conditions.
To eliminate the possibility that the lipid mixing data and the content mixing data were reflecting properties of two subpopulations of F expressing cells, rather than being a property of the same cell, we used fluorescence microscopy. The F proteins with the most varied fusion promoting activity, wt F protein and mutant A19, were used for these experiments. First, we wished to show that the lipophilic probe R18, on fusion of the R18-1abeled RBCs to F protein expressing cells was restricted to the lipid bilayer. As shown in Fig. 6 , cells expressing wt F and mutant A19 proteins showed intense fluorescent staining of the lipid bilayer. For double-labeling of RBCs the dye NBD-taurine was trapped into the aqueous interiors and the lipid dye R18 was incorporated into the cell membranes. The colabeled RBCs were bound to wt F and mutant A19 expressing cells at 4°C. After incubation at 37°C, the cells were observed by fluorescence microscopy. The colabeled RBCs transferred R18 to both wt F and A19 expressing cells under fusogenic conditions (Fig. 7) . However, only the wt F protein expressing cells took up the aqueous dye NBD-taurine. Mutant A19 expressing cells bound to RBCs became labeled with the lipid probe R18 but no cells became labeled with the aqueous content probe. Control cells maintained at 4°C did not take up any of the dyes. Hence, even though mutant A19 can promote efficient transfer of outer leaflet lipids, it failed to promote transfer of cytoplasmic contents.
It has been shown recently that ability to detect small and/or transient fusion pores between RBCs and cells can be improved by loading RBCs with 1 mM ethidium bromide (EtBr) (mol wt 394) (Melikyan et al., 1995) . Human RBCs do not contain a nucleus and are not stained strongly by EtBr. Upon fusion with cells containing a nucleus, EtBr intercalates into target cell DNA, leading to both a major increase in fluorescence quantum yield and irreversible accumulation in the cell nucleus. Thus, in an attempt to detect if small pore formation occurs with mutant A19 that could not be detected using NBD-taurine, we loaded RBCs with EtBr. Under fusogenic conditions, none of the cells expressing mutant A19 were stained with EtBr (Fig. 7) . However, many of the wt F expressing cells were found to be stained with EtBr (Fig. 7) . Very similar data were obtained using the DNA staining dye HOECHST 33258 (data not shown). Thus, the wt F protein expressing cells exhibited aqueous continuity with RBCs under fusogenic conditions whereas mutant A19 expressing cells did not, indicating that the presence of the F protein COOHterminal domain is necessary for content mixing to occur.
Discussion
The data presented here indicate that progressive deletions in the COOH-terminal region of the SV5 F protein, causes an increasingly deleterious effect on the ability of the altered F proteins to mediate the final step in fusion, content mixing, whereas there is no discernable effect on the presumptive early step in fusion, hemifusion. Operationally, the transmembrane domain of a type I integral membrane protein is defined as a COOH terminally located hydrophobic region of ~20-30 residues that is usually bounded by two charged residues. In the case of the SV5 F protein, a computer-assisted analysis of the hydrophobicity of the COOH-terminal region suggests that the transmembrane domain is residues 485-510, which would yield a 20-residue cytoplasmic tail. However, the residues assigned to the transmembrane domain form a working hypothesis, especially as on the ectodomain side of the transmembrane domain there is not a charged residue until residue 471. Furthermore, some transmembrane domains are known to tolerate a charged residue and thus lysine residue 510 and the residues up to arginine residue 519 could form part of the transmembrane domain and if this is the case the F protein would only have a cytoplasmic tail of 11 residues.
The effect of the F protein truncation mutations on cytoplasmic content mixing was not secondary to a major defect in protein oligomerization, rate of intracellular transport, or cell surface expression level. Mutant A19 showed more heterogeneous carbohydrate modifications than wt F protein and this carbohydrate modification could be prevented by synthesis of A19 F protein in the presence of deoxymannojirimycin (DMJ), an inhibitor of et-mannosidase I. When A19 was synthesized in the presence of DMJ its fusion properties were unaffected, indicating that the carbohydrate modifications did not influence fusion activity. The reason that A19 F carbohydrate chains are modified differently from wt F protein is unknown but it is interesting to note that GPI-linked HA, unlike wt HA, is also modified by heterogenous carbohydrate extensions (Kemble et al., 1993 (Kemble et al., , 1994 .
Alterations to the cytoplasmic tails of viral glycoproteins have varying effects on properties of the proteins. In some cases deletions or changes in the sequence of the cytoplasmic tail delay or inhibit intracellular transport of the proteins, e.g., paramyxovirus HN and VSV G protein (Parks and Lamb, 1990; Rose and Bergmann, 1983) . In other cases deletion or changes in the sequence of the cytoplasmic tail have little effect on intracellular transport of the proteins, e.g., Semliki Forest virus E2 glycoprotein, influenza virus HA, Rous sarcoma virus env glycoprotein, Friend murine leukemia virus env glycoprotein (Garoff et al., 1983; Jin et al., 1996; Kilpatrick et al., 1987; Perez et al., 1987; Simpson and Lamb, 1992) . For human immunodeficiency virus and simian immunodeficiency virus env glycoproteins deletion of the cytoplasmic tail does not affect intracellular transport but, by an unknown mechanism, it increases syncytia formation (Mulligan et al., 1992; Ritter et al., 1993) . Even among paramyxovirus F protein, changes in the cytoplasmic tail have varying effects on intracellular transport (Sergel and Morrison, 1995; Yao and Compans, 1995) . Deletion of the presumed cytoplasmic tail of the SV5 F protein has little effect on its intraceliular transport, thus permitting determination of effects on fusion activity.
The mechanism by which the paramyxovirus F protein mediates fusion is not understood. It seems unlikely that the F protein hydrophobic fusion peptides are freely exposed to an aqueous environment after cleavage-activation (either in the trans-Golgi network or at the cell surface) as aggregation of the F protein oligomers would most likely occur. Thus, by analogy to influenza virus HA, it has been hypothesized that the cleaved F protein undergoes a conformational change to expose the fusion peptide at the right time and in the right place (Lamb, 1993; Sergel et al., 1993) . For influenza virus HA the metastable cleaved neutral pH form of HA undergoes a low pH-induced conformational change to expose the buried fusion peptide (Skehel et al., 1982) . From the X-ray structure of a proteolytic fragment of the low pH-induced form of HA, it is known that two out-of-register c~-helical regions rearrange and form a triple stranded coiled-coil 105 A in length, with the fusion peptide at the extremity of the coiled-coil (Bullough et al., 1994) . Several studies have suggested that the paramyxovirus F fusion peptide forms an o~ helix (Brasseur et al., 1988; Hsu et al., 1981) and this putative a-helical domain is followed in the F1 protein sequence by an out-of-register 42 residue heptad repeat (Chambers et al., 1990; Lamb, 1993) . Thus, by analogy to influenza virus HA, it has been suggested that paramyxovirus F proteins may undergo a conformational change to form a related coiled-coil structure (Carr and Kim, 1993; Lamb, 1993) . However, unlike influenza virus where the biologically relevant trigger to the conformational change is low pH, the trigger for the proposed paramyxovirus conformational change has not been identified.
Hemifusion is a presumptive intermediate event in the fusion process, in which the outer but not the inner leaflets of two fusing membranes have merged but there is no mixing of their aqueous contents. Ultrastructural studies on the steps of fusion of biomembranes have indicated that an intermediate single bilayer occurs but such intermediates are very transitory structures: e.g., in exocytosis of vascular endothelial vesicles (Palade and Bruns, 1968; Palade, 1975) , zoospore secretion in Phytophythora palmivora (Pinto da Silva and Nogueira, 1977) , myoblast fusion (Kalderon and Gilula, 1979) , and the fusion of carrot protoplasts by poly (ethylene glycol) (Kanchanapoom and Boss, 1986) . Other work using fluorescent probes to study the fusion of phospholipid vesicles has also shown that under certain conditions, an intermixing of lipid probes can occur without mixing of the vesicular contents (Chernomordik et al., 1995; Ellens et al., 1985; Fischer and Parker, 1984; Helm et al., 1989 Helm et al., , 1992 Horn, 1984; Leventis et al., 1986; Neher, 1974) . Such hemifused bilayer intermediates have been observed as stable states during the fusion of planar phospholipid bilayers in model membrane systems. Hemifusion has also been detected during artificially induced fusion between biological membranes such as during electrically induced fusion of RBCs (Song et al., 1991; Stenger and Hui, 1986) and PEG induced fusion of human erythrocytes (Ahkong et al., 1987) . However, the only evidence for hemifusion in a well-characterized protein-mediated fusion system obtained to date is with a modified form of the influenza HA protein in which the transmembrane domain was substituted for a GPI anchor (Kemble et al., 1994) . Our studies with the SV5 F tail truncation mutant A19 have demonstrated hemifusion with another fusion protein. For HA, removal of the cytoplasmic tail does not affect formation of the fusion pore or content mixing (Jin et al., 1996) . However, as discussed above, removal of the HA transmembrane domain and replacement with a GPIanchor abolishes pore formation (Kemble et al., 1994; Melikyan et al., 1995) .
For influenza HA, it has been suggested that separate domains of HA may control individual steps in fusion and an elastic coupling model has been proposed (Melikyan et al., 1995) . A mechanical coupling between the ectodomain and the transmembrane domain of HA is hypothesized to be responsible for pore formation within the hemifusion diaphragm and it is suggested that the hydrophilic cytoplasmic tail may also help in destabilizing the diaphragm that separates aqueous contents (Melikyan et al., 1995) . We assume that HA and SV5 F protein mediate fusion by similar mechanisms. However, because of the difficulty in defining precisely the residues that constitute the SV5 F protein cytoplasmic tail, it cannot be determined if the HA and F protein cytoplasmic tails have differing effects on the final fusion event. If the SV5 F protein cytoplasmic tail consists of 20 residues, it is possible that the cytoplasmic tail is needed to maintain the transmembrane domain in an appropriate conformation which facilitates formation of the fusion pore but this interaction between the cytoplasmic tail and transmembrane domain is not required for HA mediated fusion. It is also possible that the hypothesized role of the cytoplasmic tail in destabilizing the hemifusion diaphragm is more critical in SV5 F proteininduced fusion. However, if the SV5 F protein cytoplasmic tail only consists of 11 residues then removal of a part of the transmembrane domain in mutant A19, may directly affect fusion pore formation.
